<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
    
    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
        <!-- AppResources meta begin -->
        <meta name="paf-app-resources" content="" />
                 <script type="text/javascript">var ncbi_startTime = new Date();</script>
            
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="" />

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-part" /><meta name="ncbi_acc" content="NBK1449" /><meta name="ncbi_domain" content="gene" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK1449/" /><meta name="ncbi_pagename" content="Alpha-Thalassemia X-Linked Intellectual Disability Syndrome - GeneReviews® - NCBI Bookshelf" /><meta name="ncbi_bookparttype" content="chapter" /><meta name="ncbi_app" content="bookshelf" />
        <!-- Logger end -->
        
        <title>Alpha-Thalassemia X-Linked Intellectual Disability Syndrome - GeneReviews® - NCBI Bookshelf</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,FOLLOW,NOARCHIVE" /><meta name="citation_inbook_title" content="GeneReviews® [Internet]" /><meta name="citation_title" content="Alpha-Thalassemia X-Linked Intellectual Disability Syndrome" /><meta name="citation_publisher" content="University of Washington, Seattle" /><meta name="citation_date" content="2014/11/06" /><meta name="citation_author" content="Roger E Stevenson" /><meta name="citation_pmid" content="20301622" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK1449/" /><meta name="citation_keywords" content="Alpha Thalassemia / Mental Retardation, X-Linked" /><meta name="citation_keywords" content="ATRX Syndrome" /><meta name="citation_keywords" content="ATRX Syndrome" /><meta name="citation_keywords" content="Alpha Thalassemia/Mental Retardation, X-Linked" /><meta name="citation_keywords" content="Transcriptional regulator ATRX" /><meta name="citation_keywords" content="ATRX" /><meta name="citation_keywords" content="Alpha-Thalassemia X-Linked Intellectual Disability Syndrome" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="Alpha-Thalassemia X-Linked Intellectual Disability Syndrome" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="University of Washington, Seattle" /><meta name="DC.Contributor" content="Roger E Stevenson" /><meta name="DC.Date" content="2014/11/06" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK1449/" /><meta name="description" content="Alpha-thalassemia X-linked intellectual disability (ATRX) syndrome is characterized by distinctive craniofacial features, genital anomalies, severe developmental delays, hypotonia, intellectual disability, and mild-to-moderate anemia secondary to alpha-thalassemia. Craniofacial abnormalities include small head circumference, telecanthus or widely spaced eyes, short nose, tented vermilion of the upper lip, and thick or everted vermilion of the lower lip with coarsening of the facial features over time. Although all affected individuals have a normal 46,XY karyotype, genital anomalies range from hypospadias and undescended testicles to severe hypospadias and ambiguous genitalia, to normal-appearing female external genitalia. Global developmental delays are evident in infancy and some affected individuals never walk independently or develop significant speech." /><meta name="og:title" content="Alpha-Thalassemia X-Linked Intellectual Disability Syndrome" /><meta name="og:type" content="book" /><meta name="og:description" content="Alpha-thalassemia X-linked intellectual disability (ATRX) syndrome is characterized by distinctive craniofacial features, genital anomalies, severe developmental delays, hypotonia, intellectual disability, and mild-to-moderate anemia secondary to alpha-thalassemia. Craniofacial abnormalities include small head circumference, telecanthus or widely spaced eyes, short nose, tented vermilion of the upper lip, and thick or everted vermilion of the lower lip with coarsening of the facial features over time. Although all affected individuals have a normal 46,XY karyotype, genital anomalies range from hypospadias and undescended testicles to severe hypospadias and ambiguous genitalia, to normal-appearing female external genitalia. Global developmental delays are evident in infancy and some affected individuals never walk independently or develop significant speech." /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK1449/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/gene/xlmr/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK1449/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books_print.min.css" type="text/css" media="print" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace}  .first-line-outdent .bk_ref {display: inline}  .body-content h2, .body-content .h2  {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list  .graphic {display:inline-block !important} .temp-labeled-list  img{width:100%}</style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/large-obj-scrollbars.min.js"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/books.min.js"> </script><meta name="book-collection" content="NONE" />

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE88E1C5E03FD8A100000000070C0299.m_12" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4098876/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/4008682/3881636/3579733/4062871/12930/3964959/3854974/36029/4128070/9685/3549676/3609192/3609193/3609213/3395586.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3411343/3882866.css" media="print" /></head>
    <body class="book-part">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo"><h1 class="res_name"><a href="/books/" title="Bookshelf home">Bookshelf</a></h1><h2 class="res_tagline"></h2></div>
    <div class="search"><form method="get" action="/books/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="books" selected="selected" class="last" data-ac_dict="bookshelf-search">Books</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books" data-ac_dict="bookshelf-search">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search Books. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'bookshelf-search',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'no'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/books/browse/">Browse Titles</a>
                    </li><li>
                        <a href="/books/advanced/">Advanced</a>
                    </li><li class="help">
                        <a href="/books/NBK3833/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <!-- Custom content 1 -->
<div class="col1">
    
</div>

<div class="container">
    <div id="maincontent" class="content eight_col col">
        <!-- Custom content in the left column above book nav -->
        <div class="col2">
            
        </div>
        
        <!-- Book content -->
        

        <!-- Custom content between navigation and content -->
        <div class="col3">
            
        </div>
        
        <div class="document">
            <div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p><p>Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. </p></div><div class="iconblock clearfix whole_rhythm no_top_margin bk_noprnt"><a class="img_link icnblk_img" title="All GeneReviews" href="/books/n/gene/"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" alt="Cover of GeneReviews®" height="100px" width="80px" /></a><div class="icnblk_cntnt eight_col"><h2>GeneReviews<sup>®</sup> [Internet].</h2><a data-jig="ncbitoggler" href="#__NBK1449_dtls__">Show details</a><div style="display:none" class="ui-widget" id="__NBK1449_dtls__"><div>Adam MP, Ardinger HH, Pagon RA, et al., editors.</div><div>Seattle (WA): <a href="http://www.washington.edu" ref="pagearea=page-banner&amp;targetsite=external&amp;targetcat=link&amp;targettype=publisher">University of Washington, Seattle</a>; 1993-2019.</div></div><div class="half_rhythm"><ul class="inline_list"><li style="margin-right:1em"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a></li></ul></div><div class="bk_noprnt"><form method="get" action="/books/n/gene/" id="bk_srch"><div class="bk_search"><label for="bk_term" class="offscreen_noflow">Search term</label><input type="text" title="Search GeneReviews" id="bk_term" name="term" value="" data-jig="ncbiclearbutton" /> <input type="submit" class="jig-ncbibutton" value="Search GeneReviews" submit="false" style="padding: 0.1em 0.4em;" /></div></form><div><ul class="inline_list"><li><a href="/books/n/gene/advanced/">GeneReviews Advanced Search</a></li><li style="margin-left:.5em"><a href="/books/n/gene/helpadvsearch/">Help</a></li></ul></div></div></div><div class="icnblk_cntnt two_col"><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/a-mannosidosis/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/a-thal/" title="Next page in this title">Next &gt;</a></div></div></div></div></div>
            <div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><h1 id="_NBK1449_"><span class="title" itemprop="name">Alpha-Thalassemia X-Linked Intellectual Disability Syndrome</span></h1><div itemprop="alternativeHeadline" class="subtitle whole_rhythm">Synonyms: Alpha Thalassemia / Mental Retardation, X-Linked; ATRX Syndrome</div><p class="contrib-group"><span itemprop="author">Roger E Stevenson</span>, MD, FACMG.</p><a data-jig="ncbitoggler" href="#__NBK1449_ai__" style="border:0;text-decoration:none">Author Information</a><div style="display:none" class="ui-widget" id="__NBK1449_ai__"><div class="contrib half_rhythm"><span itemprop="author">Roger E Stevenson</span>, MD, FACMG<div class="affiliation small">Clinical Genetics and Cytogenetics<br />Greenwood Genetic Center<br />Greenwood, South Carolina<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="gro.cgg@ser" class="oemail">gro.cgg@ser</a></div></div></div></div><p class="small">Initial Posting: <span itemprop="datePublished">June 19, 2000</span>; Last Update: <span itemprop="dateModified">November 6, 2014</span>.</p><p><em>Estimated reading time: 19 minutes</em></p></div><div class="jig-ncbiinpagenav body-content whole_rhythm" data-jigconfig="allHeadingLevels: ['h2'],smoothScroll: false" itemprop="text"><div id="xlmr.Summary" itemprop="description"><h2 id="_xlmr_Summary_">Summary</h2><div><h4 class="inline">Clinical characteristics.</h4><p>Alpha-thalassemia <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> intellectual disability (ATRX) syndrome is characterized by distinctive craniofacial features, genital anomalies, severe developmental delays, hypotonia, intellectual disability, and mild-to-moderate anemia secondary to alpha-thalassemia. Craniofacial abnormalities include small head circumference, telecanthus or widely spaced eyes, short nose, tented vermilion of the upper lip, and thick or everted vermilion of the lower lip with coarsening of the facial features over time. Although all <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals have a normal 46,XY <a class="def" href="/books/n/gene/glossary/def-item/karyotype/">karyotype</a>, genital anomalies range from hypospadias and undescended testicles to severe hypospadias and ambiguous genitalia, to normal-appearing female external genitalia. Global developmental delays are evident in infancy and some affected individuals never walk independently or develop significant speech.</p></div><div><h4 class="inline">Diagnosis/testing.</h4><p>The diagnosis of ATRX syndrome is established in individuals with somatic abnormalities, intellectual disability, hypotonia, abnormal hemoglobin H production, and a family history consistent with <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> inheritance. <i>ATRX</i> is the only <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> in which mutation causes ATRX syndrome.</p></div><div><h4 class="inline">Management.</h4><p><i>Treatment of manifestations:</i> Calorie-dense formula and/or gavage feeding as needed for adequate nutrition; anticholinergics, botulinum toxin type A injection of the salivary glands, and/or surgical redirection of the submandibular ducts for excessive drooling; early intervention programs and special education.</p><p><i>Prevention of secondary complications:</i> Antibiotic prophylaxis and vaccination to prevent pneumococcal and meningococcal infection in those with asplenia.</p><p><i>Surveillance:</i> Regular assessment of growth in infancy and childhood; regular monitoring of developmental progress.</p><p><i>Other:</i> Anemia rarely requires treatment.</p></div><div><h4 class="inline">Genetic counseling.</h4><p>ATRX syndrome is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> manner. The mother of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> may be a <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> or the <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual may have a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>. Female carriers have a 50% chance in each pregnancy of transmitting the <i>ATRX</i> pathogenic variant; offspring with a 46,XY <a class="def" href="/books/n/gene/glossary/def-item/karyotype/">karyotype</a> who inherit the <i>ATRX</i> pathogenic variant will be affected; offspring with a 46,XX karyotype who inherit the pathogenic variant are unaffected female carriers. Affected individuals do not reproduce. Carrier testing for at-risk females and prenatal testing for pregnancies at increased risk are possible if the pathogenic variant in the family is known.</p></div></div><div id="xlmr.Diagnosis"><h2 id="_xlmr_Diagnosis_">Diagnosis</h2><p><b>Diagnosis of alpha-thalassemia <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> intellectual disability (ATRX) syndrome should be suspected</b> in individuals with the following:</p><ul><li class="half_rhythm"><div>Characteristic craniofacial features, including telecanthus or widely spaced eyes, short nose, tented vermilion of the upper lip, and thick or everted vermilion of the lower lip with coarsening of the facial features over time</div></li><li class="half_rhythm"><div>Microcephaly</div></li><li class="half_rhythm"><div>Genital anomalies, including hypospadias and undescended testes, ambiguous genitalia, or normal external female genitalia in a 46,XY individual</div></li><li class="half_rhythm"><div>Skeletal anomalies, including short stature, brachydactyly, tapering fingers, clinodactyly, digital contractures, overlapping digits, pes planus, varus and valgus foot deformations, pectus carinatum, kyphosis, scoliosis, and dimpling over the lower spine</div></li><li class="half_rhythm"><div>Laboratory findings of alpha-thalassemia</div></li><li class="half_rhythm"><div>Intellectual disability, typically in the severe to profound range</div></li></ul><p>Because the phenotypic findings (with the exception of alpha-thalassemia) overlap with those of other syndromes, clinical diagnosis should be confirmed by <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a>.</p><div id="xlmr.Testing"><h3>Testing</h3><p><b>Affected individuals</b>. Hematologic studies show evidence of alpha-thalassemia in approximately 85% of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals with a 46,XY <a class="def" href="/books/n/gene/glossary/def-item/karyotype/">karyotype</a> who have an <i>ATRX</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> [<a class="bk_pop" href="#xlmr.REF.gibbons.2008.796">Gibbons et al 2008</a>].</p><ul><li class="half_rhythm"><div class="half_rhythm"><b>Red blood cell indices.</b> Although microcytic hypochromic anemia may be seen in some <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals, many have red cell indices in the normal range [<a class="bk_pop" href="#xlmr.REF.gibbons.1995a.288">Gibbons et al 1995a</a>].</div></li><li class="half_rhythm"><div class="half_rhythm"><b>HbH inclusions</b> (&#x003b2;-globin tetramers) in erythrocytes can be demonstrated following incubation of fresh blood smears with 1% brilliant cresyl blue (BCB). The proportion of cells with HbH inclusions ranges from 0.01% to 30% [<a class="bk_pop" href="#xlmr.REF.gibbons.1995b.837">Gibbons et al 1995b</a>].</div><div class="half_rhythm">Note: (1) HbH inclusions may be demonstrated readily in some individuals, found only in an occasional erythrocyte in some, or observed only after repeated testing in others. (2) The absence of HbH inclusions in 10%-20% of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals and the rarity of inclusions (&#x02264;1% of erythrocytes) in an additional 40% of affected individuals diminish the utility of this testing in most clinical settings.</div></li><li class="half_rhythm"><div class="half_rhythm"><b>Hemoglobin electrophoresis</b> can also demonstrate HbH; however, the test is not highly sensitive and may fail to identify many cases. Rare cases of ATRX syndrome have been identified through the detection of HgH on <a class="def" href="/books/n/gene/glossary/def-item/newborn-screening/">newborn screening</a> for hemoglobinopathies.</div></li></ul><p><b>Female carriers.</b> HbH inclusions are found in about 25% of female carriers [<a class="bk_pop" href="#xlmr.REF.gibbons.1995b.837">Gibbons et al 1995b</a>].</p><p><b>The diagnosis of ATRX syndrome is established in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b> by <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> (see <a class="figpopup" href="/books/NBK1449/table/xlmr.T.molecular_genetic_testing_used_in/?report=objectonly" target="object" rid-figpopup="figxlmrTmoleculargenetictestingusedin" rid-ob="figobxlmrTmoleculargenetictestingusedin">Table 1</a>).</p><p><b>One genetic testing strategy</b> is <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> of <i>ATRX</i>.</p><ul><li class="half_rhythm"><div>Sequencing of the <i>ATRX</i> zinc finger <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a> (also designated the PHD and ADD domain) and helicase domain detects more than 80% of pathogenic variants (exons 7, 8, 9, and 17-20 inclusively).</div></li><li class="half_rhythm"><div>A second level of molecular testing includes full-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> sequencing or <a class="def" href="/books/n/gene/glossary/def-item/cdna/">cDNA</a> sequencing to detect pathogenic <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> and splice variants outside the zinc finger and helicase domains.</div></li><li class="half_rhythm"><div>Duplication/<a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> analysis may be required to identify whole-<a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> and whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions or duplications and to delineate smaller deletions and duplications not readily resolved by sequencing.</div></li><li class="half_rhythm"><div>Although staining of erythrocytes with BCB to identify HbH inclusions has been a helpful and inexpensive adjunct to diagnosis in the past, its utility is diminished by the fact that in 10%-20% of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals, erythrocytes do not have these inclusions and in 40% of affected individuals, no more than 1% of erythrocytes have these inclusions. Nonetheless, the test may be useful in supporting the diagnosis in individuals with clinical findings of ATRX syndrome in whom <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> does not identify a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</div></li></ul><p><b>An alternative genetic testing strategy</b> is use of a <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a> that includes <i>ATRX</i> and other genes of interest (see <a href="#xlmr.Differential_Diagnosis">Differential Diagnosis</a>). Note: The genes included in the panel and the diagnostic <a class="def" href="/books/n/gene/glossary/def-item/sensitivity/">sensitivity</a> of the testing used for each <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> vary by laboratory and are likely to change over time. (2) Some multigene panels may include genes not associated with the condition discussed in this <i>GeneReview</i>; thus, clinicians need to determine which multigene panel is most likely to identify the genetic cause of the condition at the most reasonable cost while limiting identification of variants of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a> and pathogenic variants in genes that do not explain the underlying <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>. (3) In some laboratories, panel options may include a custom laboratory-designed panel and/or custom phenotype-focused <a class="def" href="/books/n/gene/glossary/def-item/exome/">exome</a> analysis that includes genes specified by the clinician. (4) Methods used in a panel may include <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>, <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>, and/or other non-sequencing-based tests.</p><p>For an introduction to multigene panels click <a href="/books/n/gene/app5/#app5.Multigene_Panels">here</a>. More detailed information for clinicians ordering genetic tests can be found <a href="/books/n/gene/app5/#app5.Multigene_Panels_FAQs">here</a>.</p><p><b>More comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing</b> (when available) including <a class="def" href="/books/n/gene/glossary/def-item/exome-sequencing/">exome sequencing</a>, <a class="def" href="/books/n/gene/glossary/def-item/genome-sequencing/">genome sequencing</a>, and mitochondrial sequencing may be considered if serial single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing (and/or use of a <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a> that includes <i>ATRX</i>) fails to confirm a diagnosis in an individual with features of ATRX syndrome. For an introduction to comprehensive genomic testing click <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing">here</a>. More detailed information for clinicians ordering genomic testing can be found <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing_1">here</a>.</p><p><b>Gene.</b>
<i>ATRX</i> is the only <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> known to be associated with ATRX syndrome.</p><div id="xlmr.T.molecular_genetic_testing_used_in" class="table"><h3><span class="label">Table 1. </span></h3><div class="caption"><p>Molecular Genetic Testing Used in Alpha-Thalassemia X-Linked Intellectual Disability Syndrome</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1449/table/xlmr.T.molecular_genetic_testing_used_in/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__xlmr.T.molecular_genetic_testing_used_in_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_xlmr.T.molecular_genetic_testing_used_in_1_1_1_1" rowspan="2" scope="col" colspan="1" headers="hd_h_xlmr.T.molecular_genetic_testing_used_in_1_1_1_1" style="text-align:left;vertical-align:middle;">Gene&#x000a0;<sup>1</sup></th><th id="hd_h_xlmr.T.molecular_genetic_testing_used_in_1_1_1_2" rowspan="2" scope="col" colspan="1" headers="hd_h_xlmr.T.molecular_genetic_testing_used_in_1_1_1_2" style="text-align:left;vertical-align:middle;">Test Method</th><th id="hd_h_xlmr.T.molecular_genetic_testing_used_in_1_1_1_3" colspan="2" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">Proportion of Probands with a Pathogenic Variant Detectable by This Method</th></tr><tr><th headers="hd_h_xlmr.T.molecular_genetic_testing_used_in_1_1_1_3" id="hd_h_xlmr.T.molecular_genetic_testing_used_in_1_1_2_1" colspan="1" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">Affected Males&#x000a0;<sup>2</sup></th><th headers="hd_h_xlmr.T.molecular_genetic_testing_used_in_1_1_1_3" id="hd_h_xlmr.T.molecular_genetic_testing_used_in_1_1_2_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Carrier Females</th></tr></thead><tbody><tr><td headers="hd_h_xlmr.T.molecular_genetic_testing_used_in_1_1_1_1" rowspan="3" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><i>ATRX</i></td><td headers="hd_h_xlmr.T.molecular_genetic_testing_used_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Sequence analysis of select exons&#x000a0;<sup>3,&#x000a0;4</sup></td><td headers="hd_h_xlmr.T.molecular_genetic_testing_used_in_1_1_1_3 hd_h_xlmr.T.molecular_genetic_testing_used_in_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">85%&#x000a0;<sup>5</sup></td><td headers="hd_h_xlmr.T.molecular_genetic_testing_used_in_1_1_1_3 hd_h_xlmr.T.molecular_genetic_testing_used_in_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">See footnote 6</td></tr><tr><td headers="hd_h_xlmr.T.molecular_genetic_testing_used_in_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Sequence analysis / scanning for pathogenic variants&#x000a0;<sup>7</sup></td><td headers="hd_h_xlmr.T.molecular_genetic_testing_used_in_1_1_1_3 hd_h_xlmr.T.molecular_genetic_testing_used_in_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">95%&#x000a0;<sup>5</sup></td><td headers="hd_h_xlmr.T.molecular_genetic_testing_used_in_1_1_1_3 hd_h_xlmr.T.molecular_genetic_testing_used_in_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">See footnote 6</td></tr><tr><td headers="hd_h_xlmr.T.molecular_genetic_testing_used_in_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Deletion/<a class="def" href="/books/n/gene/glossary/def-item/duplication/">duplication</a> analysis&#x000a0;<sup>8,&#x000a0;9</sup></td><td headers="hd_h_xlmr.T.molecular_genetic_testing_used_in_1_1_1_3 hd_h_xlmr.T.molecular_genetic_testing_used_in_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x0003c;5%&#x000a0;<sup>5</sup></td><td headers="hd_h_xlmr.T.molecular_genetic_testing_used_in_1_1_1_3 hd_h_xlmr.T.molecular_genetic_testing_used_in_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Unknown</td></tr><tr><td headers="hd_h_xlmr.T.molecular_genetic_testing_used_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_xlmr.T.molecular_genetic_testing_used_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="def" href="/books/n/gene/glossary/def-item/x-chromosome-inactivation/">X-chromosome inactivation</a> study</td><td headers="hd_h_xlmr.T.molecular_genetic_testing_used_in_1_1_1_3 hd_h_xlmr.T.molecular_genetic_testing_used_in_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">NA&#x000a0;<sup>10</sup></td><td headers="hd_h_xlmr.T.molecular_genetic_testing_used_in_1_1_1_3 hd_h_xlmr.T.molecular_genetic_testing_used_in_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">95% of <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> females&#x000a0;<sup>11</sup></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="xlmr.TF.1.1"><p class="no_margin">See <a href="/books/NBK1449/#xlmr.molgen.TA">Table A. Genes and Databases</a> for <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> and protein. See <a href="#xlmr.Molecular_Genetics">Molecular Genetics</a> for information on allelic variants detected in this <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>.</p></div></dd><dt>2. </dt><dd><div id="xlmr.TF.1.2"><p class="no_margin">Approximately 25% of individuals tested on the basis of suggestive clinical findings have the diagnosis confirmed by <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing [<a class="bk_pop" href="#xlmr.REF.badens.2006a.57">Badens et al 2006a</a>].</p></div></dd><dt>3. </dt><dd><div id="xlmr.TF.1.3"><p class="no_margin">Sequence analysis detects variants that are benign, likely benign, of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a>, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants; typically, <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions/duplications are not detected. For issues to consider in interpretation of <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> results, click <a href="/books/n/gene/app2/">here</a>.</p></div></dd><dt>4. </dt><dd><div id="xlmr.TF.1.4"><p class="no_margin">Sequence analysis of <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> 7, exon 8, proximal area of exon 9, and the helicase domains (exons 17-20) detects approximately 90% of known ATRX pathogenic variants [<a class="bk_pop" href="#xlmr.REF.villard.2002.223">Villard &#x00026; Fontes 2002</a>, <a class="bk_pop" href="#xlmr.REF.badens.2006a.57">Badens et al 2006a</a>, <a class="bk_pop" href="#xlmr.REF.argentaro.2007.11939">Argentaro et al 2007</a>].</p></div></dd><dt>5. </dt><dd><div id="xlmr.TF.1.5"><p class="no_margin">Lack of amplification by <a class="def" href="/books/n/gene/glossary/def-item/pcr/">PCR</a> prior to <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> can suggest a putative (multi)<a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> on the X <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> in <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> males; confirmation may require additional testing by <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>.</p></div></dd><dt>6. </dt><dd><div id="xlmr.TF.1.6"><p class="no_margin">Sequence analysis of <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> DNA cannot detect <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> of one or more exons or the entire <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> in a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> female.</p></div></dd><dt>7. </dt><dd><div id="xlmr.TF.1.7"><p class="no_margin">Sequence analysis and scanning of the entire <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> for pathogenic variants can have similar variant detection frequencies; however, detection rates for variant scanning may vary considerably between laboratories depending on the specific protocol used.</p></div></dd><dt>8. </dt><dd><div id="xlmr.TF.1.8"><p class="no_margin">Testing that identifies <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions/duplications not detectable by <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> of the coding and flanking <a class="def" href="/books/n/gene/glossary/def-item/intronic/">intronic</a> regions of <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> DNA. Methods used may include <a class="def" href="/books/n/gene/glossary/def-item/quantitative-pcr/">quantitative PCR</a>, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and <a class="def" href="/books/n/gene/glossary/def-item/chromosomal-microarray/">chromosomal microarray</a> (CMA) that includes this gene/<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> segment.</p></div></dd><dt>9. </dt><dd><div id="xlmr.TF.1.9"><p class="no_margin">Only a few deletions and duplications in <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> males and <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> females have been identified [<a class="bk_pop" href="#xlmr.REF.gibbons.2008.796">Gibbons et al 2008</a>, <a class="bk_pop" href="#xlmr.REF.lugtenberg.2009.760">Lugtenberg et al 2009</a>].</p></div></dd><dt>10. </dt><dd><div id="xlmr.TF.1.10"><p class="no_margin">Not applicable</p></div></dd><dt>11. </dt><dd><div id="xlmr.TF.1.11"><p class="no_margin">More than 95% of <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> females have marked skewing of <a class="def" href="/books/n/gene/glossary/def-item/x-chromosome-inactivation/">X-chromosome inactivation</a> (&#x0003e;90:10). However, non-random X-chromosome inactivation is not unique to ATRX syndrome; thus, the finding of skewed X-chromosome inactivation is not diagnostic and must be used in the context of clinical findings.</p></div></dd></dl></div></div></div></div></div><div id="xlmr.Clinical_Characteristics"><h2 id="_xlmr_Clinical_Characteristics_">Clinical Characteristics</h2><div id="xlmr.Clinical_Description"><h3>Clinical Description</h3><p>A more or less distinctive <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> has emerged from the study of individuals with alpha-thalassemia <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> intellectual disability (ATRX) syndrome.</p><p>Craniofacial, genital, and developmental manifestations are prominent among the most severely <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals [<a class="bk_pop" href="#xlmr.REF.gibbons.1995a.288">Gibbons et al 1995a</a>, <a class="bk_pop" href="#xlmr.REF.badens.2006a.57">Badens et al 2006a</a>, <a class="bk_pop" href="#xlmr.REF.stevenson.2012">Stevenson et al 2012</a>]. As clinical experience with the condition has increased and additional individuals/families have been evaluated using <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a>, the range of phenotypic variability has broadened, particularly on the mild end of the spectrum. Findings by <a class="bk_pop" href="#xlmr.REF.guerrini.2000.117">Guerrini et al [2000]</a> and <a class="bk_pop" href="#xlmr.REF.yntema.2002.243">Yntema et al [2002]</a> confirm this. Both describe families within which affected males have mild, moderate, or profound intellectual disability. Adults in the family described by <a class="bk_pop" href="#xlmr.REF.yntema.2002.243">Yntema et al [2002]</a> appeared to have nonsyndromic XLID, although childhood photographs showed evidence of facial hypotonia. <a class="bk_pop" href="#xlmr.REF.basehore.2015.461">Basehore et al [2015]</a> reported 25 affected males in five families with a p.Arg37Ter variant who had variable but overall milder phenotypes.</p><p>A recognizable pattern of craniofacial findings includes small head circumference, upsweep of the frontal hair, telecanthus or widely spaced eyes, short triangular nose with high insertion of the columella, tented vermilion of the upper lip, thick or everted vermilion of the lower lip, and open mouth. Irregular anatomy of the pinnae, widely spaced teeth, and protruding tongue are supplemental findings, the latter two adding to a coarseness of the facial appearance, particularly after the first few years of life.</p><p>The external genitalia are usually abnormal. The anomalies are often minor, including first-degree hypospadias, undescended testes, and underdevelopment of the scrotum. More severe defects are second- and third-degree hypospadias, small penis, and ambiguous genitalia. Although all individuals with ATRX syndrome have a normal 46,XY <a class="def" href="/books/n/gene/glossary/def-item/karyotype/">karyotype</a>, occasionally gonadal dysgenesis results in inadequate testosterone production and ambiguous genitalia or even normal-appearing female external genitalia. Although the spectrum of possible genital anomalies in ATRX syndrome is broad, the type of genital anomaly appears to be consistent within a family.</p><p>Stature is typically short (&#x0003e;2 SD below the mean in 67% of individuals using standard growth charts; syndrome-specific growth charts are not available). Short stature may be accompanied by minor skeletal anomalies (brachydactyly, clinodactyly, tapered digits, joint contractures, pectus carinatum, kyphosis, scoliosis, dimples over the lower spine, varus and valgus foot deformation, and pes planus).</p><p>Major malformations are not common, but ocular coloboma, cleft palate, cardiac defects, inguinal hernia, heterotaxy, and asplenia [<a class="bk_pop" href="#xlmr.REF.leahy.2005.37">Leahy et al 2005</a>] have been reported.</p><p>The severe developmental impairment and intellectual disability are the most important clinical manifestations. From the outset, developmental milestones are globally and markedly delayed. Speech and ambulation occur late in childhood. Some <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals never walk independently or develop significant speech.</p><p>Hypotonia is a hallmark of the condition, contributing to the facial manifestations, drooling, and developmental delays. Seizures occur in approximately one third of individuals [<a class="bk_pop" href="#xlmr.REF.gibbons.1995a.288">Gibbons et al 1995a</a>].</p><p>The majority of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals have gastrointestinal symptoms that contribute significantly to morbidity. Approximately three fourths have gastroesophageal reflux and one third have chronic constipation. Gastric pseudo-obstruction resulting from abnormal suspension of the stomach and constipation resulting from colon hypoganglionosis have been observed [<a class="bk_pop" href="#xlmr.REF.martucciello.2006.1172">Martucciello et al 2006</a>]. Aspiration, presumably related to gastroesophageal reflux, has been a fatal complication in some.</p><p>Although the neurobehavioral <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> has not been extensively delineated, most individuals appear affable, but some are emotionally labile with tantrums and bouts of prolonged crying or laughing.</p><p><b>Alpha-thalassemia.</b> A microcytic, hypochromic anemia characteristic of alpha-thalassemia may be seen, but many individuals with ATRX syndrome have normal red cell indices and normal hematocrit/hemoglobin. Pathogenic variants in <i>ATRX</i> apparently downregulate &#x003b1;-globin <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> expression in those individuals with HbH inclusions.</p></div><div id="xlmr.GenotypePhenotype_Correlations"><h3>Genotype-Phenotype Correlations</h3><p><a class="bk_pop" href="#xlmr.REF.badens.2006a.57">Badens et al [2006a]</a> found that pathogenic variants that affect the ATRX zinc finger <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a> produce severe psychomotor impairment and urogenital anomalies, whereas pathogenic variants in the helicase domains cause milder phenotypes. A <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a> variant in <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> 2 (p.Arg37Ter) appears to be a common <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> that results in an overall milder <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> [<a class="bk_pop" href="#xlmr.REF.guerrini.2000.117">Guerrini et al 2000</a>, <a class="bk_pop" href="#xlmr.REF.abidi.2005.176">Abidi et al 2005</a>, <a class="bk_pop" href="#xlmr.REF.basehore.2015.461">Basehore et al 2015</a>].</p><p>Heterozygous females rarely show clinical manifestations.</p><ul><li class="half_rhythm"><div><a class="bk_pop" href="#xlmr.REF.badens.2006b.2212">Badens et al [2006b]</a> reported a girl conceived by in vitro fertilization (IVF) who had craniofacial features, growth retardation, and developmental impairment typical of ATRX syndrome. Leukocyte studies showed marked skewing of <a class="def" href="/books/n/gene/glossary/def-item/x-chromosome-inactivation/">X-chromosome inactivation</a> with her <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>-bearing X chromosome being the active X chromosome. The role of IVF in this unique case of female expression is not known.</div></li><li class="half_rhythm"><div><a class="bk_pop" href="#xlmr.REF.wada.2005.18">Wada et al [2005]</a> reported moderate intellectual disability without other phenotypic features of ATRX syndrome in a female <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> with random <a class="def" href="/books/n/gene/glossary/def-item/x-chromosome-inactivation/">X-chromosome inactivation</a>.</div></li></ul></div><div id="xlmr.Penetrance"><h3>Penetrance</h3><p>Penetrance is presumed to be 100% in males as <i>ATRX</i> pathogenic variants have not been reported in normal males.</p></div><div id="xlmr.Nomenclature"><h3>Nomenclature</h3><p>"Alpha-thalassemia <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> intellectual disability syndrome" and "ATRX syndrome" are the preferred designations for this disorder.</p><p>Carpenter-Waziri syndrome, Holmes-Gang syndrome, Chudley-Lowry syndrome and XLID-arch fingerprints-hypotonia syndrome are allelic, each reported in a single family, and clinically similar to ATRX syndrome [<a class="bk_pop" href="#xlmr.REF.stevenson.1997.465">Stevenson et al 1997</a>, <a class="bk_pop" href="#xlmr.REF.abidi.1999.249">Abidi et al 1999</a>, <a class="bk_pop" href="#xlmr.REF.stevenson.2000.383">Stevenson et al 2000</a>, <a class="bk_pop" href="#xlmr.REF.abidi.2005.176">Abidi et al 2005</a>]; they are now considered to be in the phenotypic spectrum of ATRX syndrome and thus no compelling reason remains to retain their names.</p><p>Such is not the case for Juberg-Marsidi syndrome and Smith-Fineman-Myers syndrome (see <a href="#xlmr.Genetically_Related_Allelic_Disorde">Genetically Related Disorders</a>).</p></div><div id="xlmr.Prevalence"><h3>Prevalence</h3><p>The prevalence is not known. More than 200 <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals are known to the laboratories conducting <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a>; substantial under-ascertainment, especially of those with milder phenotypes, is probable.</p><p>No racial or ethnic concentration of individuals has been reported.</p></div></div><div id="xlmr.Genetically_Related_Allelic_Disorde"><h2 id="_xlmr_Genetically_Related_Allelic_Disorde_">Genetically Related (Allelic) Disorders</h2><p><i>ATRX</i> pathogenic variants have been found in several named <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> intellectual disability (XLID) syndromes (Carpenter-Waziri syndrome, Holmes-Gang syndrome, Chudley-Lowry syndrome, XLID-arch fingerprints &#x02013; hypotonia), XLID with spastic paraplegia, XLID with epilepsy, and nonsyndromic XLID [<a class="bk_pop" href="#xlmr.REF.lossi.1999.558">Lossi et al 1999</a>, <a class="bk_pop" href="#xlmr.REF.stevenson.2000.174">Stevenson 2000</a>, <a class="bk_pop" href="#xlmr.REF.stevenson.2000.383">Stevenson et al 2000</a>, <a class="bk_pop" href="#xlmr.REF.yntema.2002.243">Yntema et al 2002</a>, <a class="bk_pop" href="#xlmr.REF.stevenson.2012">Stevenson et al 2012</a>]. These entities should be considered to be in the phenotypic spectrum of ATRX syndrome; there are no compelling reasons to maintain the <a class="def" href="/books/n/gene/glossary/def-item/syndromic/">syndromic</a> names.</p><p><i>ATRX</i> pathogenic variants have also been identified in families reported as having Juberg-Marsidi syndrome and Smith-Fineman-Myers syndrome [<a class="bk_pop" href="#xlmr.REF.villard.a">Villard et al 1999a</a>]. The original family described as having Juberg-Marsidi syndrome has been restudied and found to have a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>HUWE1</i> and no pathogenic variant in <i>ATRX</i> [<a class="bk_pop" href="#xlmr.REF.friez.2011">Friez et al 2011</a>]. The original family reported with Smith-Fineman-Myers syndrome has not been restudied; hence the relationship between ATRX syndrome and Smith-Fineman-Myers syndrome is unclear.</p></div><div id="xlmr.Differential_Diagnosis"><h2 id="_xlmr_Differential_Diagnosis_">Differential Diagnosis</h2><p><a href="/books/n/gene/cls/"><b>Coffin-Lowry syndrome</b></a>
<b>(CLS)</b> is usually characterized by severe to profound intellectual disability in males and normal intelligence to profound intellectual disability in <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> females. The facial appearance is characteristic in the <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> older male child or adult. The hands are short, soft, and fleshy, often with remarkably hyperextensible tapering fingers. Short stature, microcephaly, and dental anomalies are common. Childhood-onset <i>s</i>timulus-<i>i</i>nduced <i>d</i>rop <i>a</i>ttack<i>s</i> (SIDAs) in which unexpected tactile or auditory stimuli or excitement triggers a brief collapse but no loss of consciousness are present in approximately 20% of individuals. Progressive kyphoscoliosis and early mortality are seen. Pathogenic variants in <i>RPS6KA3</i> are causative. Inheritance is X linked.</p><p><a href="/books/n/gene/mecp2-dup/"><b><i>MECP2</i> duplication syndrome</b></a> is characterized by severe intellectual disability, spasticity, infantile hypotonia, absent or limited speech, seizures, and recurrent respiratory infections [<a class="bk_pop" href="#xlmr.REF.friez.2006.e1687">Friez et al 2006</a>]. In addition to the core features, autistic behaviors and gastrointestinal dysfunction have been observed in several <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> boys. Half of affected males die by early adulthood. Marked skewing of <a class="def" href="/books/n/gene/glossary/def-item/x-chromosome-inactivation/">X-chromosome inactivation</a> occurs in most <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> females. The face is not as characteristically hypotonic as in ATRX syndrome, nor does microcephaly occur as commonly. Duplications of <i>MECP2</i> ranging from 0.3 to 4 Mb are found in all affected males. Inheritance is <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a>.</p><p><a href="/books/n/gene/a-thal/"><b>Alpha-thalassemia</b></a><b>.</b> Hemoglobin H (HbH) disease, one of the two clinically significant forms of alpha-thalassemia, is characterized by microcytic hypochromic hemolytic anemia, hepatosplenomegaly, mild jaundice, and sometimes thalassemia-like bone changes; it results from reduced production of the &#x003b1; chains of adult hemoglobin (designated Hb &#x003b1;<sub>2</sub>&#x003b2;<sub>2</sub>). In individuals with developmental delay who are of Mediterranean, Southeast Asian, or African American origin, it is appropriate to determine the &#x003b1;-globin <a class="def" href="/books/n/gene/glossary/def-item/genotype/">genotype</a>. Individuals with ATRX syndrome have a normal &#x003b1;-globin genotype (&#x003b1;&#x003b1;/&#x003b1;&#x003b1;), whereas those with HbH disease have <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> or dysfunction of three of four &#x003b1;-globin alleles. Intellectual disability is not a component of alpha-thalassemia involving &#x003b1;-globin production.</p><p><b>Alpha-thalassemia mental retardation <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> 16 (ATR-16)</b> (OMIM <a href="http://omim.org/entry/141750" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">141750</a>) is the association of alpha-thalassemia and intellectual disability in individuals with a <a class="def" href="/books/n/gene/glossary/def-item/contiguous-gene-deletion/">contiguous gene deletion</a> involving the distal short arm of chromosome 16. Such deletions produce alpha-thalassemia by deleting the two genes in <a class="def" href="/books/n/gene/glossary/def-item/cis/"><i>cis</i></a> configuration at 16p13 that encode &#x003b1;-globin chains. Because the chromosome deletions and rearrangements giving rise to ATR-16 are large and variable, no specific clinical <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> is observed in ATR-16; this is in contrast to ATRX syndrome, in which the phenotype is more predictable.</p></div><div id="xlmr.Management"><h2 id="_xlmr_Management_">Management</h2><div id="xlmr.Evaluations_Following_Initial_Diagn"><h3>Evaluations Following Initial Diagnosis</h3><p>To establish the extent of disease and needs in an individual diagnosed with alpha-thalassemia <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> intellectual disability (ATRX) syndrome, the following evaluations are recommended:</p><ul><li class="half_rhythm"><div>Review of medical history for developmental progress and seizures</div></li><li class="half_rhythm"><div>Assessment of growth in infants and children</div></li><li class="half_rhythm"><div>Physical examination including assessment of facial features, muscle tone, and deep tendon reflexes</div></li><li class="half_rhythm"><div>Assessment of cognitive and adaptive functions by neuropsychological testing</div></li><li class="half_rhythm"><div>Auscultation of the heart for evidence of structural defect</div></li><li class="half_rhythm"><div>Examination of the genitalia for cryptorchidism and other anomalies</div></li><li class="half_rhythm"><div>Assessment of feeding in early childhood for swallowing difficulties, gastroesophageal reflux, and/ or recurrent vomiting</div></li><li class="half_rhythm"><div>Ophthalmologic evaluation for strabismus, visual acuity problems, or structural eye defects if indicated by clinical assessment</div></li><li class="half_rhythm"><div>Consultation with a clinical geneticist and/or genetic counselor</div></li></ul></div><div id="xlmr.Treatment_of_Manifestations"><h3>Treatment of Manifestations</h3><p>The following treatments are recommended:</p><ul><li class="half_rhythm"><div>Calorie-dense formula and/or gavage feeding to compensate for poor nutritional intake</div></li><li class="half_rhythm"><div>If food refusal is an issue, evaluation for gastrointestinal causes such as peptic ulcer disease</div></li><li class="half_rhythm"><div>If drooling is a serious problem, treatment with anticholinergics, botulinum toxin type A injection of the salivary glands and/or surgical redirecting of the submandibular ducts</div></li><li class="half_rhythm"><div>Treatment in the usual manner for gastroesophageal reflux, recurrent respiratory and urinary tract infections, seizures, severe behavior problems, anomalies (e.g., cleft palate, cardiac malformations, cryptorchidism, ambiguous genitalia, hypospadias)</div></li><li class="half_rhythm"><div>Early intervention programs and special education for developmental delays</div></li></ul></div><div id="xlmr.Prevention_of_Secondary_Complicatio"><h3>Prevention of Secondary Complications</h3><p>Antibiotic prophylaxis and vaccination to prevent pneumococcal and meningococcal infection are reasonable precautions in the rare patient with asplenia [<a class="bk_pop" href="#xlmr.REF.leahy.2005.37">Leahy et al 2005</a>].</p></div><div id="xlmr.Surveillance"><h3>Surveillance</h3><p>Growth should be followed regularly in infancy and childhood and plotted on age-appropriate growth charts. (Syndrome-specific growth charts are not available.)</p><p>Developmental progress should be monitored throughout infancy and childhood.</p></div><div id="xlmr.Evaluation_of_Relatives_at_Risk"><h3>Evaluation of Relatives at Risk</h3><p>See <a href="#xlmr.Related_Genetic_Counseling_Issues">Genetic Counseling</a> for issues related to testing of at-risk relatives for <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> purposes.</p></div><div id="xlmr.Therapies_Under_Investigation"><h3>Therapies Under Investigation</h3><p>Search <a href="https://clinicaltrials.gov/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ClinicalTrials.gov</a> in the US and <a href="http://www.ClinicalTrialsRegister.eu" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.ClinicalTrialsRegister.eu</a> in Europe for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.</p></div><div id="xlmr.Other"><h3>Other</h3><p>Anemia, if present, is mild and rarely requires treatment.</p></div></div><div id="xlmr.Genetic_Counseling"><h2 id="_xlmr_Genetic_Counseling_">Genetic Counseling</h2><p>
<i>Genetic counseling is the process of providing individuals and families with
information on the nature, inheritance, and implications of genetic disorders to help them
make informed medical and personal decisions. The following section deals with genetic
risk assessment and the use of family history and genetic testing to clarify genetic
status for family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with a genetics
professional</i>. &#x02014;ED.</p><div id="xlmr.Mode_of_Inheritance"><h3>Mode of Inheritance</h3><p>Alpha-thalassemia <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> intellectual disability (ATRX) syndrome is inherited in an X-linked manner.</p></div><div id="xlmr.Risk_to_Family_Members"><h3>Risk to Family Members</h3><p><b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>In a family with more than one <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual, the mother of an affected individual is an <a class="def" href="/books/n/gene/glossary/def-item/obligate-carrier/">obligate carrier</a> of an <i>ATRX</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</div></li><li class="half_rhythm"><div>In families with only one <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual, the mother may be a <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> or the affected individual may have ATRX syndrome as a result of a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>. No data on the frequency of <i>de novo</i> mutation in this condition are available.</div></li></ul><p><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> The risk to sibs of a proband depends on the <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> status of the mother:</p><ul><li class="half_rhythm"><div>If the mother of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> has a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, the chance of transmitting it is 50% in each pregnancy. Sibs with a 46,XY <a class="def" href="/books/n/gene/glossary/def-item/karyotype/">karyotype</a> who inherit the pathogenic variant will be <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>; sibs with a 46,XX karyotype who inherit the pathogenic variant are female carriers and will not be affected.</div></li><li class="half_rhythm"><div>If the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> represents a <a class="def" href="/books/n/gene/glossary/def-item/simplex/">simplex</a> case (i.e., a single occurrence in a family) and if the <i>ATRX</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> cannot be detected in the leukocyte DNA of the mother, the risk to sibs is low but greater than that of the general population because of the possibility of maternal <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a>. Maternal mosaicism (somatic and germline) for a pathogenic variant of <i>ATRX</i> has resulted in recurrent ATRX syndrome in two brothers [<a class="bk_pop" href="#xlmr.REF.shimbo.2014.408">Shimbo et al 2014</a>].</div></li></ul><p><b>Offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> No <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual has reproduced.</p><p><b>Other family members of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> The proband's maternal aunts and their offspring may be at risk of being carriers or being <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>.</p></div><div id="xlmr.Carrier_Detection"><h3>Carrier Detection</h3><p>Carrier testing of at-risk female relatives is possible if the <i>ATRX</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> has been identified in the family.</p></div><div id="xlmr.Related_Genetic_Counseling_Issues"><h3>Related Genetic Counseling Issues</h3><p><b>Family planning</b></p><ul><li class="half_rhythm"><div>The optimal time for determination of genetic risk, clarification of <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> status, and discussion of the availability of prenatal testing is before pregnancy.</div></li><li class="half_rhythm"><div>It is appropriate to offer <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> (including discussion of potential risks to offspring and reproductive options) to young adults who are <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>, are carriers, or are at risk of being carriers.</div></li></ul><p><b>Assisted reproduction technologies (ART).</b> Donor eggs may be utilized by <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> females to avoid the risk of transmitting an <i>ATRX</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>. Although experience with ART in ATRX syndrome is limited, one female conceived by IVF had total inactivation of her normal X <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> and the physical and psychomotor findings typical of ATRX syndrome in males [<a class="bk_pop" href="#xlmr.REF.badens.2006b.2212">Badens et al 2006b</a>].</p><p><b>DNA banking</b> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p></div><div id="xlmr.Prenatal_Testing_and_Preimplantatio"><h3>Prenatal Testing and Preimplantation Genetic Diagnosis</h3><p>Once the <i>ATRX</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> has been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, prenatal testing for a pregnancy at increased risk and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> are possible.</p><p><b>High-risk pregnancies.</b> For pregnancies in which the mother has been identified as being <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> for the <i>ATRX</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> identified in the family, the usual procedure is to determine fetal sex on cells obtained from amniocentesis (usually performed at ~15-18 weeks' gestation) or chorionic villus sampling (usually performed at ~10-12 weeks' gestation). If the fetus has a 46,XY <a class="def" href="/books/n/gene/glossary/def-item/karyotype/">karyotype</a>, DNA can be analyzed to determine if the <i>ATRX</i> pathogenic variant identified in the family is present.</p><p>Note: Gestational age is expressed as menstrual weeks calculated either from the first day of the last normal menstrual period or by ultrasound measurements.</p><p><b>Indeterminate-risk pregnancies.</b> Germline <a class="def" href="/books/n/gene/glossary/def-item/mosaicism/">mosaicism</a> has been documented in ATRX syndrome [<a class="bk_pop" href="#xlmr.REF.bachoo.1999.933">Bachoo &#x00026; Gibbons 1999</a>, <a class="bk_pop" href="#xlmr.REF.shimbo.2014.408">Shimbo et al 2014</a>]; thus, the mother of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> who does not demonstrate the <i>ATRX</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in her leukocytes is still at risk of having a second <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> child. Prenatal diagnosis as described for high-risk pregnancies should be offered for all XY fetuses.</p></div></div><div id="xlmr.Resources"><h2 id="_xlmr_Resources_">Resources</h2><p>
<i>GeneReviews staff has selected the following disease-specific and/or umbrella
support organizations and/or registries for the benefit of individuals with this disorder
and their families. GeneReviews is not responsible for the information provided by other
organizations. For information on selection criteria, click <a href="/books/n/gene/app4/">here</a>.</i></p><ul><li class="half_rhythm"><div><b>American Association on Intellectual and Developmental Disabilities (AAIDD)</b></div><div>501 3rd Street Northwest</div><div>Suite 200</div><div>Washington DC 20001</div><div><b>Phone:</b> 202-387-1968</div><div><b>Fax:</b> 202-387-2193</div><div><b>Email:</b> sis@aaidd.org</div><div><a href="http://www.aaidd.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.aaidd.org</a></div></li><li class="half_rhythm"><div><b>Medline Plus</b></div><div><a href="http://www.nlm.nih.gov/medlineplus/ency/article/001523.htm" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Intellectual Disability</a></div></li></ul></div><div id="xlmr.Molecular_Genetics"><h2 id="_xlmr_Molecular_Genetics_">Molecular Genetics</h2><p><i>Information in the Molecular Genetics and OMIM tables may differ from that elsewhere in the GeneReview: tables may contain more recent information. &#x02014;</i>ED.</p><div id="xlmr.molgen.TA" class="table"><h3><span class="label">Table A.</span></h3><div class="caption"><p>Alpha-Thalassemia X-Linked Intellectual Disability Syndrome: Genes and Databases</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1449/table/xlmr.molgen.TA/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__xlmr.molgen.TA_lrgtbl__"><table class="no_bottom_margin"><tbody><tr><th id="hd_b_xlmr.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Gene</th><th id="hd_b_xlmr.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">Chromosome Locus</th><th id="hd_b_xlmr.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">Protein</th><th id="hd_b_xlmr.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">Locus-Specific Databases</th><th id="hd_b_xlmr.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">HGMD</th><th id="hd_b_xlmr.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;">ClinVar</th></tr><tr><td headers="hd_b_xlmr.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/546" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>ATRX</i></a></td><td headers="hd_b_xlmr.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=546" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Xq21<wbr style="display:inline-block"></wbr>​.1</a></td><td headers="hd_b_xlmr.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/P46100" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Transcriptional regulator ATRX</a></td><td headers="hd_b_xlmr.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.LOVD.nl/ATRX" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ATRX @ LOVD</a></td><td headers="hd_b_xlmr.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=ATRX" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ATRX</a></td><td headers="hd_b_xlmr.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=ATRX[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ATRX</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div id="xlmr.TFA.1"><p class="no_margin">Data are compiled from the following standard references: <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> from
<a href="http://www.genenames.org/index.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HGNC</a>;
<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> from
<a href="http://www.omim.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">OMIM</a>;
protein from <a href="http://www.uniprot.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">UniProt</a>.
For a description of databases (Locus Specific, HGMD, ClinVar) to which links are provided, click
<a href="/books/n/gene/app1/">here</a>.</p></div></dd></dl></div></div></div><div id="xlmr.molgen.TB" class="table"><h3><span class="label">Table B.</span></h3><div class="caption"><p>OMIM Entries for Alpha-Thalassemia X-Linked Intellectual Disability Syndrome (<a href="/omim/300032,301040" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">View All in OMIM</a>) </p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1449/table/xlmr.molgen.TB/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__xlmr.molgen.TB_lrgtbl__"><table><tbody><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/300032" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">300032</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">ATR-X GENE; ATRX</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/301040" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">301040</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, X-LINKED; ATRX</td></tr></tbody></table></div></div><p><b>Gene structure.</b> The <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> extends over 350 kb and includes 35 exons. For a detailed summary of gene and protein information, see <a href="/books/NBK1449/#xlmr.molgen.TA">Table A</a>, <b>Gene</b>.</p><p><b>Pathogenic variants.</b> Although pathogenic variants have been distributed throughout <i>ATRX</i>, more than 90% of those reported are in regions encoding the zinc finger and helicase domains [<a class="bk_pop" href="#xlmr.REF.villard.1999b.183">Villard et al 1999b</a>, <a class="bk_pop" href="#xlmr.REF.villard.2002.223">Villard &#x00026; Fontes 2002</a>, <a class="bk_pop" href="#xlmr.REF.borgione.2003.529">Borgione et al 2003</a>, <a class="bk_pop" href="#xlmr.REF.badens.2006a.57">Badens et al 2006a</a>, <a class="bk_pop" href="#xlmr.REF.argentaro.2007.11939">Argentaro et al 2007</a>, <a class="bk_pop" href="#xlmr.REF.thienpont.2007.1094">Thienpont et al 2007</a>]. Deletions, insertions, intragenic duplications, and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and splice variants have been found. Missense variants appear more commonly than do frameshift and nonsense variants. For more information, see <a href="/books/NBK1449/#xlmr.molgen.TA">Table A</a>, <b>Gene</b>.</p><div id="xlmr.T.atrx_pathogenic_variants_discusse" class="table"><h3><span class="label">Table 2. </span></h3><div class="caption"><p><i>ATRX</i> Pathogenic Variants Discussed in This <i>GeneReview</i></p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1449/table/xlmr.T.atrx_pathogenic_variants_discusse/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__xlmr.T.atrx_pathogenic_variants_discusse_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_xlmr.T.atrx_pathogenic_variants_discusse_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">DNA Nucleotide Change</th><th id="hd_h_xlmr.T.atrx_pathogenic_variants_discusse_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Predicted Protein Change</th><th id="hd_h_xlmr.T.atrx_pathogenic_variants_discusse_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Reference Sequences</th></tr></thead><tbody><tr><td headers="hd_h_xlmr.T.atrx_pathogenic_variants_discusse_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.109C&#x0003e;T</td><td headers="hd_h_xlmr.T.atrx_pathogenic_variants_discusse_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg37Ter</td><td headers="hd_h_xlmr.T.atrx_pathogenic_variants_discusse_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/nuccore/NM_000489.4" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_000489<wbr style="display:inline-block"></wbr>​.4</a><br /><a href="/protein/NP_000480.3" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_000480<wbr style="display:inline-block"></wbr>​.3</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">Note on variant classification: Variants listed in the table have been provided by the author. <i>GeneReviews</i> staff have not independently verified the classification of variants.</p></div></dd><dt></dt><dd><div><p class="no_margin">Note on nomenclature: <i>GeneReviews</i> follows the standard naming conventions of the Human Genome Variation Society (<a href="http://varnomen.hgvs.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">varnomen<wbr style="display:inline-block"></wbr>​.hgvs.org</a>). See <a href="/books/n/gene/app3/">Quick Reference</a> for an explanation of nomenclature.</p></div></dd></dl></div></div></div><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> Zinc finger <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a> functions as a <a class="def" href="/books/n/gene/glossary/def-item/transcription-factor/">transcription factor</a>; the helicase domains function in the transcription process opening double-stranded DNA. In combination with other chromatin-associated proteins, the ATRX protein appears to play a role in chromatin remodeling, possibly silencing gene expression during development [<a class="bk_pop" href="#xlmr.REF.xue.2003.10635">Xue et al 2003</a>, <a class="bk_pop" href="#xlmr.REF.ausi_.2003.83">Ausi&#x000f3; et al 2003</a>, <a class="bk_pop" href="#xlmr.REF.tang.2004a.20369">Tang et al 2004a</a>, <a class="bk_pop" href="#xlmr.REF.tang.2004b.339">Tang et al 2004b</a>, <a class="bk_pop" href="#xlmr.REF.kernohan.2010.191">Kernohan et al 2010</a>].</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> The mutated ATRX protein downregulates the &#x003b1;-globin <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a>, resulting in thalassemia, and probably suppresses expression of other genes by disturbances in transcription and chromatin structure, leading to malformations and intellectual disability [<a class="bk_pop" href="#xlmr.REF.tang.2004a.20369">Tang et al 2004a</a>, <a class="bk_pop" href="#xlmr.REF.tang.2004b.339">Tang et al 2004b</a>, <a class="bk_pop" href="#xlmr.REF.argentaro.2007.11939">Argentaro et al 2007</a>, <a class="bk_pop" href="#xlmr.REF.nan.2007.2709">Nan et al 2007</a>, <a class="bk_pop" href="#xlmr.REF.ritchie.2008.315">Ritchie et al 2008</a>, <a class="bk_pop" href="#xlmr.REF.kernohan.2010.191">Kernohan et al 2010</a>].</p></div><div id="xlmr.References"><h2 id="_xlmr_References_">References</h2><div id="xlmr.Literature_Cited"><h3>Literature Cited</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="xlmr.REF.abidi.1999.249">Abidi F, Schwartz CE, Carpenter NJ, Villard L, Font&#x000e9;s M, Curtis M. Carpenter-Waziri syndrome results from a mutation in XNP. <span><span class="ref-journal">Am J Med Genet. </span>1999;<span class="ref-vol">85</span>:249–51.</span> [<a href="/pubmed/10398237" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10398237</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="xlmr.REF.abidi.2005.176">Abidi FE, Cardoso C, Lossi AM, Lowry RB, Depetris D, Matt&#x000e9;i MG, Lubs HA, Stevenson RE, Fontes M, Chudley AE, Schwartz CE. Mutation in the 5' alternatively spliced region of the XNP/ATR-X gene causes Chudley-Lowry syndrome. <span><span class="ref-journal">Eur J Hum Genet. </span>2005;<span class="ref-vol">13</span>:176–83.</span> [<a href="/pubmed/15508018" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15508018</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="xlmr.REF.argentaro.2007.11939">Argentaro A, Yang JC, Chapman L, Kowalczyk MS, Gibbons RJ, Higgs DR, Neuhaus D, Rhodes D. Structural consequences of disease-causing mutations in the ATRX-DNMT3-DNMT3L (ADD) domain of the chromatin-associated protein ATRX. <span><span class="ref-journal">Proc Natl Acad Sci U S A. </span>2007;<span class="ref-vol">104</span>:11939–44.</span> [<a href="/pmc/articles/PMC1924575/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1924575</span></a>] [<a href="/pubmed/17609377" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17609377</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="xlmr.REF.ausi_.2003.83">Ausi&#x000f3; J, Levin DB, De Amorim GV, Bakker S, Macleod PM. Syndromes of disordered chromatin remodeling. <span><span class="ref-journal">Clin Genet. </span>2003;<span class="ref-vol">64</span>:83–95.</span> [<a href="/pubmed/12859401" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12859401</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="xlmr.REF.bachoo.1999.933">Bachoo S, Gibbons RJ. Germline and gonosomal mosaicism in the ATR-X syndrome. <span><span class="ref-journal">Eur J Hum Genet. </span>1999;<span class="ref-vol">7</span>:933–6.</span> [<a href="/pubmed/10602370" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10602370</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="xlmr.REF.badens.2006a.57">Badens C, Lacoste C, Philip N, Martini N, Courrier S, Giuliano F, Verloes A, Munnich A, Leheup B, Burglen L, Odent S, Van Esch H, Levy N. Mutations in PHD-like domain of the ATRX gene correlate with severe psychomotor impairment and severe urogenital abnormalities in patients with ATRX syndrome. <span><span class="ref-journal">Clin Genet. </span>2006a;<span class="ref-vol">70</span>:57–62.</span> [<a href="/pubmed/16813605" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16813605</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="xlmr.REF.badens.2006b.2212">Badens C, Martini N, Courrier S, DesPortes V, Touraine R, Levy N, Edery P. ATRX syndrome in a girl with a heterozygous mutation in the ATRX Zn finger domain and a totally skewed X-inactivation pattern. <span><span class="ref-journal">Am J Med Genet A. </span>2006b;<span class="ref-vol">140</span>:2212–5.</span> [<a href="/pubmed/16955409" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16955409</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="xlmr.REF.basehore.2015.461">Basehore MJ, Michaelson-Cohen R, Levy-Lahad E, Sismani C, Bird LM, Friez MJ, Walsh T, Abidi F, Holloway L, Skinner C, McGee S, Alexandrou A, Syrrou M, Patsalis PC, Raymond G, Wang T, Schwartz CE, King MC, Stevenson RE. Alpha-thalassemia intellectual disability: variable phenotypic expression among males with a recurrent nonsense mutation - c.109C&#x0003e;T (p.R37X). <span><span class="ref-journal">Clin Genet. </span>2015;<span class="ref-vol">87</span>:461–6.</span> [<a href="/pubmed/24805811" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24805811</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="xlmr.REF.borgione.2003.529">Borgione E, Sturnio M, Spalletta A, Angela Lo Giudice M, Castiglia L, Galesi O, Ragusa A, Fichera M. Mutational analysis of the ATRX gene by DGGE: a powerful diagnostic approach for the ATRX syndrome. <span><span class="ref-journal">Hum Mutat. </span>2003;<span class="ref-vol">21</span>:529–34.</span> [<a href="/pubmed/12673795" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12673795</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="xlmr.REF.friez.2006.e1687">Friez MJ, Jones JR, Clarkson K, Lubs H, Abuelo D, Bier JA, Pai S, Simensen R, Williams C, Giampietro PF, Schwartz CE, Stevenson RE. Recurrent infections, hypotonia, and mental retardation caused by duplication of MECP2 and adjacent region in Xq28. <span><span class="ref-journal">Pediatrics. </span>2006;<span class="ref-vol">118</span>:e1687–95.</span> [<a href="/pubmed/17088400" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17088400</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="xlmr.REF.friez.2011">Friez MJ, Brooks SS, Abidi F, Schwartz CE, Stevenson RE. Juberg-Marsidi syndrome and Brooks syndreome are allelic X-linked intellectual disability syndrome due to a HUWE1 mutation. Berlin, Germany: 15th International Workshop on Fragile X and other Early-Onset Cognitive Disorders. 2011.</div></li><li class="half_rhythm"><div class="bk_ref" id="xlmr.REF.gibbons.1995a.288">Gibbons RJ, Brueton L, Buckle VJ, Burn J, Clayton-Smith J, Davison BC, Gardner RJ, Homfray T, Kearney L, Kingston HM, Newbury-Ecob R, Porteous MEP, Wilkie AOM, Higgs DR. Clinical and hematologic aspects of the X-linked alpha-thalassemia/mental retardation syndrome (ATR-X). <span><span class="ref-journal">Am J Med Genet. </span>1995a;<span class="ref-vol">55</span>:288–99.</span> [<a href="/pubmed/7726225" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 7726225</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="xlmr.REF.gibbons.1995b.837">Gibbons RJ, Picketts DJ, Villard L, Higgs DR. Mutations in a putative global transcriptional regulator cause X-linked mental retardation with alpha-thalassemia (ATR-X syndrome). <span><span class="ref-journal">Cell. </span>1995b;<span class="ref-vol">80</span>:837–45.</span> [<a href="/pubmed/7697714" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 7697714</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="xlmr.REF.gibbons.2008.796">Gibbons RJ, Wada T, Fisher CA, Malik N, Mitson MJ, Steensma DP, Fryer A, Goudie DR, Krantz ID, Traeger-Synodinos J. Mutations in the chromatin-associated protein ATRX. <span><span class="ref-journal">Hum Mutat. </span>2008;<span class="ref-vol">29</span>:796–802.</span> [<a href="/pubmed/18409179" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18409179</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="xlmr.REF.guerrini.2000.117">Guerrini R, Shanahan JL, Carrozzo R, Bonanni P, Higgs DR, Gibbons RJ. A nonsense mutation of the ATRX gene causing mild mental retardation and epilepsy. <span><span class="ref-journal">Ann Neurol. </span>2000;<span class="ref-vol">47</span>:117–21.</span> [<a href="/pubmed/10632111" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10632111</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="xlmr.REF.kernohan.2010.191">Kernohan KD, Jiang Y, Tremblay DC, Bonvissuto AC, Eubanks JH, Mann MR, B&#x000e9;rub&#x000e9; NG. ATRX partners with cohesin and MeCP2 and contributes to developmental silencing of imprinted genes in the brain. <span><span class="ref-journal">Dev Cell. </span>2010;<span class="ref-vol">18</span>:191–202.</span> [<a href="/pubmed/20159591" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20159591</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="xlmr.REF.leahy.2005.37">Leahy RT, Philip RK, Gibbons RJ, Fisher C, Suri M, Reardon W. Asplenia in ATR-X syndrome: a second report. <span><span class="ref-journal">Am J Med Genet A. </span>2005;<span class="ref-vol">139</span>:37–9.</span> [<a href="/pubmed/16222662" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16222662</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="xlmr.REF.lossi.1999.558">Lossi AM, Mill&#x000e1;n JM, Villard L, Orellana C, Cardoso C, Prieto F, Font&#x000e9;s M, Mart&#x000ed;nez F. Mutation of the XNP/ATR-X gene in a family with severe mental retardation, spastic paraplegia and skewed pattern of X inactivation: demonstration that the mutation is involved in the inactivation bias. <span><span class="ref-journal">Am J Hum Genet. </span>1999;<span class="ref-vol">65</span>:558–62.</span> [<a href="/pmc/articles/PMC1377954/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1377954</span></a>] [<a href="/pubmed/10417298" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10417298</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="xlmr.REF.lugtenberg.2009.760">Lugtenberg D, de Brouwer AP, Oudakker AR, Pfundt R, Hamel BC, van Bokhoven H, Bongers EM. Xq13.2q21.1 duplication encompassing the ATRX gene in a man with mental retardation, minor facial and genital anomalies, short stature and broad thorax. <span><span class="ref-journal">Am J Med Genet A. </span>2009;<span class="ref-vol">149A</span>:760–6.</span> [<a href="/pubmed/19291773" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19291773</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="xlmr.REF.martucciello.2006.1172">Martucciello G, Lombardi L, Savasta S, Gibbons RJ. Gastrointestinal phenotype of ATR-X syndrome. <span><span class="ref-journal">Am J Med Genet A. </span>2006;<span class="ref-vol">140</span>:1172–6.</span> [<a href="/pubmed/16688741" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16688741</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="xlmr.REF.nan.2007.2709">Nan X, Hou J, Maclean A, Nasir J, Lafuente MJ, Shu X, Kriaucionis S, Bird A. Interaction between chromatin proteins MECP2 and ATRX is disrupted by mutations that cause inherited mental retardation. <span><span class="ref-journal">Proc Natl Acad Sci U S A. </span>2007;<span class="ref-vol">104</span>:2709–14.</span> [<a href="/pmc/articles/PMC1796997/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1796997</span></a>] [<a href="/pubmed/17296936" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17296936</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="xlmr.REF.ritchie.2008.315">Ritchie K, Seah C, Moulin J, Isaac C, Dick F, B&#x000e9;rub&#x000e9; NG. Loss of ATRX leads to chromosome cohesion and congression defects. <span><span class="ref-journal">J Cell Biol. </span>2008;<span class="ref-vol">180</span>:315–24.</span> [<a href="/pmc/articles/PMC2213576/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2213576</span></a>] [<a href="/pubmed/18227278" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18227278</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="xlmr.REF.shimbo.2014.408">Shimbo H, Ninomiya S, Kurosawa K, Wada T. A case report of two brothers with ATR-X syndrome due to low maternal frequency of somatic mosaicism for an intragenic deletion in the <em>ATRX</em>. <span><span class="ref-journal">J Hum Genet. </span>2014;<span class="ref-vol">59</span>:408–10.</span> [<a href="/pubmed/24898829" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24898829</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="xlmr.REF.stevenson.1997.465">Stevenson RE, H&#x000e4;ne B, Arena JF, May M, Lawrence L, Lubs HA, Schwartz CE. Arch fingerprints, hypotonia, and areflexia associated with X linked mental retardation. <span><span class="ref-journal">J Med Genet. </span>1997;<span class="ref-vol">34</span>:465–9.</span> [<a href="/pmc/articles/PMC1050968/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1050968</span></a>] [<a href="/pubmed/9192265" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9192265</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="xlmr.REF.stevenson.2000.174">Stevenson RE. Splitting and lumping in the nosology of XLMR. <span><span class="ref-journal">Am J Med Genet. </span>2000;<span class="ref-vol">97</span>:174–82.</span> [<a href="/pubmed/11449485" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11449485</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="xlmr.REF.stevenson.2000.383">Stevenson RE, Abidi F, Schwartz CE, Lubs HA, Holmes LB. Holmes-Gang syndrome is allelic with XLMR-hypotonic face syndrome. <span><span class="ref-journal">Am J Med Genet. </span>2000;<span class="ref-vol">94</span>:383–5.</span> [<a href="/pubmed/11050622" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11050622</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="xlmr.REF.stevenson.2012">Stevenson RE, Schwartz CE, Rogers RC. <em>Atlas of X-Linked Intellectual Disability Syndromes</em>. 2 ed. Oxford, UK: Oxford University Press; 2012:17-19.</div></li><li class="half_rhythm"><div class="bk_ref" id="xlmr.REF.tang.2004a.20369">Tang J, Wu S, Liu H, Stratt R, Barak OG, Shiekhattar R, Picketts DJ, Yang X. A novel transcription regulatory complex containing death domain-associated protein and the ATR-X syndrome protein. <span><span class="ref-journal">J Biol Chem. </span>2004a;<span class="ref-vol">279</span>:20369–77.</span> [<a href="/pubmed/14990586" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14990586</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="xlmr.REF.tang.2004b.339">Tang P, Park DJ, Marshall Graves JA, Harley VR. ATRX and sex differentiation. <span><span class="ref-journal">Trends Endocrinol Metab. </span>2004b;<span class="ref-vol">15</span>:339–44.</span> [<a href="/pubmed/15350606" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15350606</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="xlmr.REF.thienpont.2007.1094">Thienpont B, de Ravel T, Van Esch H, Van Schoubroeck D, Moerman P, Vermeesch JR, Fryns JP, Froyen G, Lacoste C, Badens C, Devriendt K. Partial duplications of the ATRX gene cause the ATR-X syndrome. <span><span class="ref-journal">Eur J Hum Genet. </span>2007;<span class="ref-vol">15</span>:1094–7.</span> [<a href="/pubmed/17579672" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17579672</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="xlmr.REF.villard.a">Villard L, Ades LC, Gecz J, Fontes M. Identification of a mutation in the XNP/ATR-X gene in a Smith-Fineman-Myers family: are ATR-X and SFM allelic syndromes? Strasbourg, France: 9th International Workshop on Fragile X Syndrome and X-Linked Mental Retardation. 1999a.</div></li><li class="half_rhythm"><div class="bk_ref" id="xlmr.REF.villard.1999b.183">Villard L, Bonino MC, Abidi F, Ragusa A, Belougne J, Lossi AM, Seaver L, Bonnefont JP, Romano C, Fichera M, Lacombe D, Hanauer A, Philip N, Schwartz C, Font&#x000e9;s M. Evaluation of a mutation screening strategy for sporadic cases of ATR-X syndrome. <span><span class="ref-journal">J Med Genet. </span>1999b;<span class="ref-vol">36</span>:183–6.</span> [<a href="/pmc/articles/PMC1734331/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1734331</span></a>] [<a href="/pubmed/10204841" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10204841</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="xlmr.REF.villard.2002.223">Villard L, Fontes M. Alpha-thalassemia/mental retardation syndrome, X-Linked (ATR-X, MIM #301040, ATR-X/XNP/XH2 gene MIM #300032). <span><span class="ref-journal">Eur J Hum Genet. </span>2002;<span class="ref-vol">10</span>:223–5.</span> [<a href="/pubmed/12032728" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12032728</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="xlmr.REF.wada.2005.18">Wada T, Sugie H, Fukushima Y, Saitoh S. Non-skewed X-inactivation may cause mental retardation in a female carrier of X-linked alpha-thalassemia/mental retardation syndrome (ATR-X): X-inactivation study of nine female carriers of ATR-X. <span><span class="ref-journal">Am J Med Genet A. </span>2005;<span class="ref-vol">138</span>:18–20.</span> [<a href="/pubmed/16100724" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16100724</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="xlmr.REF.xue.2003.10635">Xue Y, Gibbons R, Yan Z, Yang D, McDowell TL, Sechi S, Qin J, Zhou S, Higgs D, Wang W. The ATRX syndrome protein forms a chromatin-remodeling complex with Daxx and localizes in promyelocytic leukemia nuclear bodies. <span><span class="ref-journal">Proc Natl Acad Sci U S A. </span>2003;<span class="ref-vol">100</span>:10635–40.</span> [<a href="/pmc/articles/PMC196856/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC196856</span></a>] [<a href="/pubmed/12953102" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12953102</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="xlmr.REF.yntema.2002.243">Yntema HG, Poppelaars FA, Derksen E, Oudakker AR, van Roosmalen T, Jacobs A, Obbema H, Brunner HG, Hamel BC, van Bokhoven H. Expanding phenotype of XNP mutations: mild to moderate mental retardation. <span><span class="ref-journal">Am J Med Genet. </span>2002;<span class="ref-vol">110</span>:243–7.</span> [<a href="/pubmed/12116232" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12116232</span></a>]</div></li></ul></div></div><div id="xlmr.Chapter_Notes"><h2 id="_xlmr_Chapter_Notes_">Chapter Notes</h2><div id="xlmr.Author_Notes"><h3>Author Notes</h3><p>Web: <a href="http://www.ggc.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Greenwood Genetic Center</a></p><p>Dr Stevenson's work focuses on the clinical and laboratory delineation of intellectual disability and birth defects.</p></div><div id="xlmr.Revision_History"><h3>Revision History</h3><ul><li class="half_rhythm"><div>6 November 2014 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>3 June 2010 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>13 August 2009 (cd) Revision: <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> no longer available clinically</div></li><li class="half_rhythm"><div>15 October 2007 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>27 October 2006 (cd) Revision: mutation scanning clinically available</div></li><li class="half_rhythm"><div>24 March 2006 (cd) Revision: <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> of all 35 exons and associated splice junctions of <i>ATRX</i> clinically available</div></li><li class="half_rhythm"><div>14 June 2005 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>15 April 2003 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>19 June 2000 (me) Review posted live</div></li><li class="half_rhythm"><div>29 November 1999 (rs) Original submission</div></li></ul></div></div><div id="bk_toc_contnr"></div></div></div>
            <div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright</a> © 1993-2019, University of Washington, Seattle. GeneReviews is
a registered trademark of the University of Washington, Seattle. All rights
reserved.<p class="small">GeneReviews® chapters are owned by the University of Washington. Permission is
hereby granted to reproduce, distribute, and translate copies of content materials for
noncommercial research purposes only, provided that (i) credit for source (<a href="http://www.genereviews.org/" ref="pagearea=meta&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">http://www.genereviews.org/</a>) and copyright (© 1993-2019 University of
Washington) are included with each copy; (ii) a link to the original material is provided
whenever the material is published elsewhere on the Web; and (iii) reproducers,
distributors, and/or translators comply with the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>. No further modifications are allowed. For clarity, excerpts
of GeneReviews chapters for use in lab reports and clinic notes are a permitted
use.</p><p class="small">For more information, see the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>.</p><p class="small">For questions regarding permissions or whether a specified use is allowed,
contact: <a href="mailto:dev@null" data-email="ude.wu@tssamda" class="oemail">ude.wu@tssamda</a>.</p></div><div class="small"><span class="label">Bookshelf ID: NBK1449</span><span class="label">PMID: <a href="/pubmed/20301622" title="PubMed record of this page" ref="pagearea=meta&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">20301622</a></span></div><div style="margin-top:2em" class="bk_noprnt"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/a-mannosidosis/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/a-thal/" title="Next page in this title">Next &gt;</a></div></div></div></div>
            
        </div>

        <!-- Custom content below content -->
        <div class="col4">
            
        </div>
        
        
        <!-- Book content -->
        
        <!-- Custom contetnt below bottom nav -->
        <div class="col5">
            
        </div>
    </div>

    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            <div id="ncbi_share_book"><a href="#" class="ncbi_share" data-ncbi_share_config="popup:false,shorten:true" ref="id=NBK1449&amp;db=books">Share</a></div>

        </div>
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Views</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PDF_download" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/NBK1449/?report=reader">PubReader</a></li><li><a href="/books/NBK1449/?report=printable">Print View</a></li><li><a data-jig="ncbidialog" href="#_ncbi_dlg_citbx_NBK1449" data-jigconfig="width:400,modal:true">Cite this Page</a><div id="_ncbi_dlg_citbx_NBK1449" style="display:none" title="Cite this Page"><div class="bk_tt">Stevenson RE. Alpha-Thalassemia X-Linked Intellectual Disability Syndrome. 2000 Jun 19 [Updated 2014 Nov 6]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. <span class="bk_cite_avail"></span></div></div></li><li><a href="/books/NBK1449/pdf/Bookshelf_NBK1449.pdf">PDF version of this page</a> (192K)</li><li><a href="#" class="toggle-glossary-link" title="Enable/disable links to the glossary">Disable Glossary Links</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>In this GeneReview</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="page-toc" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="#xlmr.Summary" ref="log$=inpage&amp;link_id=inpage">Summary</a></li><li><a href="#xlmr.Diagnosis" ref="log$=inpage&amp;link_id=inpage">Diagnosis</a></li><li><a href="#xlmr.Clinical_Characteristics" ref="log$=inpage&amp;link_id=inpage">Clinical Characteristics</a></li><li><a href="#xlmr.Genetically_Related_Allelic_Disorde" ref="log$=inpage&amp;link_id=inpage">Genetically Related (Allelic) Disorders</a></li><li><a href="#xlmr.Differential_Diagnosis" ref="log$=inpage&amp;link_id=inpage">Differential Diagnosis</a></li><li><a href="#xlmr.Management" ref="log$=inpage&amp;link_id=inpage">Management</a></li><li><a href="#xlmr.Genetic_Counseling" ref="log$=inpage&amp;link_id=inpage">Genetic Counseling</a></li><li><a href="#xlmr.Resources" ref="log$=inpage&amp;link_id=inpage">Resources</a></li><li><a href="#xlmr.Molecular_Genetics" ref="log$=inpage&amp;link_id=inpage">Molecular Genetics</a></li><li><a href="#xlmr.References" ref="log$=inpage&amp;link_id=inpage">References</a></li><li><a href="#xlmr.Chapter_Notes" ref="log$=inpage&amp;link_id=inpage">Chapter Notes</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>GeneReviews Links</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/gene/advanced/"><i>GeneReviews</i> Advanced Search</a></li><li><a href="/books/n/gene/glossary/"><i>GeneReviews</i> Glossary</a></li><li><a href="/books/n/gene/resource_mats/">Resource Materials</a> <span class="bk_hlight1">NEW FEATURE</span></li><li><a href="/books/n/gene/updates/">New in <i>GeneReviews</i></a></li><li><a href="/books/n/gene/authors/">Author List</a></li><li><a href="/books/n/gene/prospective_authors/">For Current/Prospective Authors</a></li><li><a href="/books/n/gene/GRpersonnel/"><i>GeneReviews</i> Personnel</a></li><li><a href="/books/n/gene/howto_linkin/">Download/Link to <i>GeneReviews</i></a></li><li><a href="/books/n/gene/contact_us/">Contact Us</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Tests in GTR by Gene</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=546[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">ATRX</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Related information</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="discovery_db_links" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=omim&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_omim&amp;IdsFromResult=1479608" ref="log$=recordlinks">OMIM</a><div class="brieflinkpop offscreen_noflow">Related OMIM records</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pmc&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pmc_refs&amp;IdsFromResult=1479608" ref="log$=recordlinks">PMC</a><div class="brieflinkpop offscreen_noflow">PubMed Central citations</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pubmed&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pubmed_refs&amp;IdsFromResult=1479608" ref="log$=recordlinks">PubMed</a><div class="brieflinkpop offscreen_noflow">Links to PubMed</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=gene&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_gene&amp;IdsFromResult=1479608" ref="log$=recordlinks">Gene</a><div class="brieflinkpop offscreen_noflow">Locus Links</div></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/24278995" ref="ordinalpos=1&amp;linkpos=1&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">CASK</i>-Related Disorders</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">CASK</i>-Related Disorders<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Moog U, Uyanik G, Kutsche K. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/21882399" ref="ordinalpos=1&amp;linkpos=2&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Kabuki Syndrome</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Kabuki Syndrome<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Adam MP, Hudgins L, Hannibal M. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301398" ref="ordinalpos=1&amp;linkpos=3&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Simpson-Golabi-Behmel Syndrome Type 1</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Simpson-Golabi-Behmel Syndrome Type 1<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Sajorda BJ, Gonzalez-Gandolfi CX, Hathaway ER, Kalish JM. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301602" ref="ordinalpos=1&amp;linkpos=4&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Androgen Insensitivity Syndrome</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Androgen Insensitivity Syndrome<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Gottlieb B, Trifiro MA. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301502" ref="ordinalpos=1&amp;linkpos=5&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> X-Linked Opitz G/BBB Syndrome</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> X-Linked Opitz G/BBB Syndrome<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Meroni G. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li></ul><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=20301622" ref="ordinalpos=1&amp;log$=relatedreviews_seeall&amp;logdbfrom=pubmed">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=20301622" ref="ordinalpos=1&amp;log$=relatedarticles_seeall&amp;logdbfrom=pubmed">See all...</a></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Recent Activity</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" id="Shutter"></a></div><div class="portlet_content"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class=""><div class="action"><a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a></div><ul id="activity"><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="/portal/utils/pageresolver.fcgi?recordid=5e040fbcdde08911697a8939">Alpha-Thalassemia X-Linked Intellectual Disability Syndrome - GeneReviews®</a><div class="ralinkpop offscreen_noflow">Alpha-Thalassemia X-Linked Intellectual Disability Syndrome - GeneReviews®<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li></ul><p class="HTOn">Your browsing activity is empty.</p><p class="HTOff">Activity recording is turned off.</p><p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p><a class="seemore" href="/sites/myncbi/recentactivity">See more...</a></div></div></div>
        
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script type="text/javascript" src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script type="text/javascript">
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-12-25T20:41:16-05:00&amp;Snapshot=%2Fprojects%2Fbooks%2FPBooks@5.22&amp;Host=portal101&amp;ncbi_phid=CE88E1C5E03FD8A100000000070C0299&amp;ncbi_session=CE88E1C5E040FBB1_1804SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK1449%2F&amp;Db=pmc&amp;folderID=134&amp;Ncbi_App=bookshelf&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        </div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=books&amp;ncbi_pdid=book-part&amp;ncbi_acc=NBK1449&amp;ncbi_domain=gene&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/NBK1449/&amp;ncbi_pagename=Alpha-Thalassemia X-Linked Intellectual Disability Syndrome - GeneReviews® - NCBI Bookshelf&amp;ncbi_bookparttype=chapter&amp;ncbi_app=bookshelf" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE88E1C5E040FBB1_1804SID /projects/books/PBooks@5.22 portal101 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/js/3879255/4121861/3501987/4008961/3893018/3821238/4062932/4123007/4087685/4076480/3921943/3400083/3426610.js" snapshot="books"></script></body>
</html>